SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-22-030948
Filing Date
2022-02-08
Accepted
2022-02-08 15:28:01
Documents
3
Group Members
CANAAN 2020 CO INVESTMENT L.P. SERIES 7CANAAN PARTNERS 2020 CO INVESTMENT LLCCANAAN PARTNERS XI LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d304292dsc13g.htm SC 13G 89486
2 EXHIBIT 24 d304292dex9924.htm EX-99.24 13687
3 EXHIBIT 99.1 d304292dex991.htm EX-99.1 6263
  Complete submission text file 0001193125-22-030948.txt   111011
Mailing Address 285 RIVERSIDE AVENUE SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVENUE SUITE 250 WESTPORT CT 06880 203-855-0400
Canaan XI L.P. (Filed by) CIK: 0001712417 (see all company filings)

IRS No.: 981377917 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Subject) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92865 | Film No.: 22600891
SIC: 2834 Pharmaceutical Preparations